A Study Exploring Olaparib and Temozolomide in Small Cell Lung Cancer
3 Views
administrator
07/14/23
Anna Farago, MD, PhD, assistant, medicine, Massachusetts General Hospital, discusses a phase I study of olaparib (Lynparza) and temozolomide (Temodar) in patients with small cell lung cancer who had progression after 1 prior line of platinum-based chemotherapy.
-
Category
Show more
Facebook Comments
No comments found